Ruxolitinib Phosphate
Used for the treatment of patients with intermediate or high-risk myelofibrosis, including primary myelofibrosis, post-polycythemia vera myelofibrosis and post-essential thrombocythemia myelofibrosis. It has a role as an antineoplastic agent and an EC 2.7.10.2 (non-specific protein-tyrosine kinase) inhibitor.
| Catalog Number | API1092939177 |
| Alternative Name(s) | Jakafi;Jakavi;(R)-3-(4-(7H-Pyrrolo[2,3-d]pyrimidin-4-yl)-1H-pyrazol-1-yl)-3-cyclopentylpropanenitrile phosphate |
| Research Area | Anti-Tumor APIs |
| Molecular Formula | C17H21N6O4P |
| CAS# | 1092939-17-7 |
| SMILES | C1CCC(C1)C(CC#N)N2C=C(C=N2)C3=C4C=CNC4=NC=N3.OP(=O)(O)O |
| Size | inquiry |
| Supplier Page | https://www.protheragen-ing.com/ruxolitinib-phosphate-item-6374.html |